​

Boundless Bio Ownership | Who Owns Boundless Bio?

OverviewForecastFinancialsChart

Boundless Bio Ownership Summary

Boundless Bio is owned by 17.88% institutional investors, 11.40% insiders, and 70.73% retail investors. Ra capital management is the largest institutional shareholder, holding 9.78% of BOLD shares.

BOLD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBoundless Bio17.88%11.40%70.73%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management2.18M9.78%$3.29M
Redmile group725.20K3.25%$1.10M
Sectoral asset management678.57K3.04%$1.02M
Pfm health sciences, lp240.51K1.08%$363.18K
Sio capital management162.06K0.73%$244.71K
Amalgamated bank---
Squarepoint ops---
Ubs oconnor---
Deutsche bank ag\---
Bridgeway capital management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sectoral asset management678.57K0.80%$1.02M
Redmile group725.20K0.10%$1.10M
Sio capital management162.06K0.07%$244.71K
Ra capital management2.18M0.06%$3.29M
Pfm health sciences, lp240.51K0.03%$363.18K
Amalgamated bank---
Squarepoint ops---
Ubs oconnor---
Deutsche bank ag\---
Bridgeway capital management---

Top Buyers

HolderShares% AssetsChange
Ra capital management2.18M0.06%-
Sio capital management162.06K0.07%-
Pfm health sciences, lp240.51K0.03%-
Sectoral asset management678.57K0.80%-
Deutsche bank ag\---97.00

Top Sellers

HolderShares% AssetsChange
Ubs oconnor---140.00K
Bridgeway capital management---50.00K
Squarepoint ops---32.18K
Redmile group725.20K0.10%-15.00K
Two sigma investments, lp---13.81K

Sold Out

HolderChange
Deutsche bank ag\-97.00
Nelson, van denburg & campbell wealth management group-122.00
Amalgamated bank-218.00
Sg americas securities-10.75K
Verition fund management-11.66K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20255-90.74%3,986,980-69.24%170.53%--100.00%1-66.67%
Dec 31, 2024541.89%12,962,527-1.19%581.68%3760.87%3-81.25%
Sep 30, 20245312.77%13,118,509-5.23%581.49%23-30.30%16100.00%
Jun 30, 20244711.90%13,842,210-4.62%621.48%33-21.43%8-
Mar 31, 202442-14,512,563-65-42---

Recent Insider Transactions

DateNameRoleActivityValue
Nov 08, 2019Patterson Matthew R Chief Executive OfficerSell$432.78K
Aug 12, 2019Patterson Matthew R Chief Executive OfficerSell$34.52K
Aug 12, 2019Patterson Matthew R Chief Executive OfficerSell$646.31K
Feb 25, 2019Patterson Matthew R Chief Executive OfficerSell$120.00K
Oct 01, 2018Patterson Matthew R Chief Executive OfficerSell$202.73K

BOLD Ownership FAQ

Who Owns Boundless Bio?

Boundless Bio shareholders are primarily institutional investors at 17.88%, followed by 11.40% insiders and 70.72% retail investors. The average institutional ownership in Boundless Bio's industry, Biotech Stocks , is 63.96%, which Boundless Bio falls below.

Who owns the most shares of Boundless Bio?

Boundless Bio’s largest shareholders are Ra capital management (2.18M shares, 9.78%), Redmile group (725.2K shares, 3.25%), and Sectoral asset management (678.57K shares, 3.04%). Together, they hold 16.07% of Boundless Bio’s total shares outstanding.

Does Blackrock own Boundless Bio?

BlackRock is not among the top 10 institutional shareholders of Boundless Bio.

Who is Boundless Bio’s biggest shareholder by percentage of total assets invested?

Sectoral asset management is Boundless Bio’s biggest shareholder by percentage of total assets invested, with 0.80% of its assets in 678.57K Boundless Bio shares, valued at 1.02M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools